In a large population analysis over a two-year period, nearly 3,000 cancer patients averaging 60 years of age, each with various types of cancer (about half with Stage 4 cancer; about half stating their pain was "extreme") were given cannabis medication primarily for pain, inducing sleep, and against nausea and lack of appetite.
96% reported an improvement in their condition.
Ninety. Six. Percent.
The Israeli research team that led the study included the godfather of cannabis research, Raphael Mechoulam, the man who first identified cannabinoids (active compounds in the plant) and the system of receptors that make them effective.
(American Cannabis Report readers will recall that we recommended Dr. Mechoulam for a Nobel Prize in Medicine)
In their write-up the researchers conservatively concluded, “Cannabis as a palliative treatment for cancer patients seems to be well tolerated, effective and safe option to help patients cope with the malignancy-related symptoms.”
